GENEVA, Oct. 5 -- NOVARTIS AG filed a patent application (IB2026/052749) for “THERAPEUTIC ANTI-BAFF-R ANTIBODIES”. With publication no. WO/2026/202689, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: C07K 16/28
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....